.Nature Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint asks for introduction of people with MASLD as well as measurement of liver end results in cardio-- kidney-- metabolic trials, when data suggest mechanistically plausible benefits and professional safety-- as well as outlines factors for test concept and also regulatory commendation.